These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29168888)

  • 1. Apparent seronegative maternal shingles with post-natal mother-to-baby transmission of varicella zoster virus.
    Pan L; Singh N; Cannon R; Fawke J; Tang JW
    J Med Virol; 2018 Apr; 90(4):779-781. PubMed ID: 29168888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mother-to-Child Transfer of Reactivated Varicella-Zoster Virus DNA and Varicella-Zoster IgG in Pregnancy.
    Ranjan V; Mishra A; Kesarwani A; Mohan KV; Lal SN; Puliyel J; Upadhyay P
    Viral Immunol; 2020 Mar; 33(2):72-76. PubMed ID: 31834852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to varicella zoster virus in the cerebrospinal fluid of neonates with seizures.
    Mustonen K; Mustakangas P; Smeds M; Mannonen L; Uotila L; Vaheri A; Koskiniemi M
    Arch Dis Child Fetal Neonatal Ed; 1998 Jan; 78(1):F57-61. PubMed ID: 9536843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid, sensitive, and specific lateral-flow immunochromatographic point-of-care device for detection of varicella-zoster virus immunoglobulin G antibodies in fingerstick blood.
    Vafai N; Self K; Sheffield B; Hojvat S; Kusi-Appiah A; Vaughan P; Cowan E; Vafai A
    J Immunol Methods; 2023 Mar; 514():113429. PubMed ID: 36690067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal analysis of varicella-zoster virus-specific antibodies in systemic lupus erythematosus: No association with subclinical viral reactivations or lupus disease activity.
    Rondaan C; van Leer CC; van Assen S; Bootsma H; de Leeuw K; Arends S; Bos NA; Westra J
    Lupus; 2018 Jul; 27(8):1271-1278. PubMed ID: 29667858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance characteristics of a quantitative, standardised varicella zoster IgG time resolved fluorescence immunoassay (VZV TRFIA) for measuring antibody following natural infection.
    Chris Maple PA; Gray J; Brown K; Brown D
    J Virol Methods; 2009 Apr; 157(1):90-2. PubMed ID: 19135089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of anti-varicella zoster IgG antibody in undergraduate students.
    Bhattarakosol P; Chantarabul S; Pittayathikhun K; Mung-mee V; Punnarugsa V
    Asian Pac J Allergy Immunol; 1996 Dec; 14(2):129-31. PubMed ID: 9177828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the performance of the LIAISON VZV-IgG and VIDAS automated enzyme linked fluorescent immunoassays with reference to a VZV-IgG time-resolved fluorescence immunoassay and implications of choice of cut-off for LIAISON assay.
    Maple PA; Rathod P; Smit E; Gray J; Brown D; Boxall EH
    J Clin Virol; 2009 Jan; 44(1):9-14. PubMed ID: 18823815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal antibody titers against varicella-zoster virus in relation to gestational age, birth weight, and maternal titer.
    van Der Zwet WC; Vandenbroucke-Grauls CM; van Elburg RM; Cranendonk A; Zaaijer HL
    Pediatrics; 2002 Jan; 109(1):79-85. PubMed ID: 11773545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of varicella-zoster virus in Korea.
    Choi WS; Noh JY; Huh JY; Jo YM; Lee J; Song JY; Kim WJ; Cheong HJ
    J Med Virol; 2010 Dec; 82(12):2123-6. PubMed ID: 20981803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral load and antibody boosting following herpes zoster diagnosis.
    Warren-Gash C; Forbes H; Maple P; Quinlivan M; Breuer J
    J Clin Virol; 2018 Jun; 103():12-15. PubMed ID: 29602095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis.
    Kohlmann R; Salmen A; Chan A; Knabbe C; Diekmann J; Brockmeyer N; Skaletz-Rorowski A; Michalik C; Gold R; Überla K
    Mult Scler; 2015 Dec; 21(14):1823-32. PubMed ID: 25828755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of a history of prior varicella/herpes zoster infection in multiple sclerosis.
    Manouchehrinia A; Tanasescu R; Kareem H; Jerca OP; Jabeen F; Shafei R; Breuer J; Neal K; Irving W; Constantinescu CS
    J Neurovirol; 2017 Dec; 23(6):839-844. PubMed ID: 28895088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological detection of varicella-zoster virus-specific immunoglobulin G by an enzyme-linked immunosorbent assay using glycoprotein antigen.
    Sauerbrei A; Wutzler P
    J Clin Microbiol; 2006 Sep; 44(9):3094-7. PubMed ID: 16954232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of Varicella-Zoster virus IgG antibodies in Swiss children during the first 16 months of age.
    Heininger U; Desgrandchamps D; Schaad UB
    Vaccine; 2006 Apr; 24(16):3258-60. PubMed ID: 16459000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgM to varicella-zoster virus: demonstration in patients with and without clinical zoster.
    Gershon AA; Steinberg SP; Borkowsky W; Lennette D; Lennette E
    Pediatr Infect Dis; 1982; 1(3):164-7. PubMed ID: 6292875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The differences in short- and long-term varicella-zoster virus (VZV) immunoglobulin G levels following varicella vaccination of healthcare workers measured by VZV fluorescent-antibody-to-membrane-antigen assay (FAMA), VZV time-resolved fluorescence immunoassay and a VZV purified glycoprotein enzyme immunoassay.
    Maple PA; Haedicke J; Quinlivan M; Steinberg SP; Gershon AA; Brown KE; Breuer J
    Epidemiol Infect; 2016 Aug; 144(11):2345-53. PubMed ID: 27018820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of varicella-zoster virus and predictors for seronegativity in the Amsterdam adult population.
    van Rijckevorsel GG; Damen M; Sonder GJ; van der Loeff MF; van den Hoek A
    BMC Infect Dis; 2012 Jun; 12():140. PubMed ID: 22721551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgE anti-varicella zoster virus and other immune responses before, during, and after shingles.
    Smith-Norowitz TA; Josekutty J; Lev-Tov H; Kohlhoff S; Norowitz KB; Silverberg JI; Chice S; Durkin HG; Bluth MH
    Ann Clin Lab Sci; 2009; 39(1):43-50. PubMed ID: 19201740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome in newborn babies given anti-varicella-zoster immunoglobulin after perinatal maternal infection with varicella-zoster virus.
    Miller E; Cradock-Watson JE; Ridehalgh MK
    Lancet; 1989 Aug; 2(8659):371-3. PubMed ID: 2569560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.